Squamous Cell Non-small Cell Lung Cancer Clinical Trials

13 clinical trials for Squamous Cell Non-small Cell Lung Cancer across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of ZW251 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC) — RECRUITING · PHASE1
• Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ） — RECRUITING · PHASE3
• A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201) — TERMINATED · PHASE1
• MGD019 DART® Protein in Unresectable/Metastatic Cancer — COMPLETED · PHASE1
• Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
• SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer — TERMINATED · PHASE3
• HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors — OTHER · PHASE1
• Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017) — COMPLETED · PHASE3
• Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC) — TERMINATED · PHASE2
• Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens — COMPLETED · PHASE2
• A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer — COMPLETED · PHASE2

Refine this search